These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14925749)

  • 1. [Erythroderma due to diphenyl hydantoin].
    VERMENOUZE ; HERMABESSIERE O
    Bull Soc Fr Dermatol Syphiligr; 1951; 58(5):543. PubMed ID: 14925749
    [No Abstract]   [Full Text] [Related]  

  • 2. [Exfoliative dermatitis after hydantoin therapy].
    HATZMANN I; NEUHOLD R; VON RITTNER W
    Ann Paediatr; 1952 Nov; 179(5):305-16. PubMed ID: 13017343
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of experimental intoxication of antiepileptic drugs (phenobarbital, 5-5-diphenyl-hydantoin, tridione).
    NARITA Y
    Folia Psychiatr Neurol Jpn; 1960 Dec; 14():367-98. PubMed ID: 13727807
    [No Abstract]   [Full Text] [Related]  

  • 4. A METHOD FOR EVALUATION OF PHYSIOLOGICAL AVAILABILITY OF DIPHENYL HYDANTOIN BY URINARY ANALYSIS.
    PANALAKS T
    Clin Chim Acta; 1963 Nov; 8():968-70. PubMed ID: 14089572
    [No Abstract]   [Full Text] [Related]  

  • 5. Another fatality following the use of tridione and an hydantoin.
    GAYLE RF; LYNCH JP; SCHERER JH
    Va Med Mon (1918); 1948 Jun; 75(6):288-91. PubMed ID: 18868603
    [No Abstract]   [Full Text] [Related]  

  • 6. Polyarteritis nodosa: a review together with report of a case due to hydantoin sensitization treated with cortisone.
    FRANKEL AL; ROTHERMICH NO
    Ohio State Med J; 1951 Nov; 47(11):1013-21. PubMed ID: 14882762
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gingival changes under the influence of hydantoin preparations].
    HAYM J
    Nervenarzt; 1959 Aug; 30():370-2. PubMed ID: 14400348
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary changes in hydantoin therapy.
    MOORE MT
    J Am Med Assoc; 1959 Nov; 171():1328-33. PubMed ID: 14423879
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experiences with a new anti-epileptic drug: hydotin (3-methyl-5,5-diphenyl-hydantoin)].
    CASTELLUCCIO R
    Sem Med; 1952 Apr; 100(14):405-8. PubMed ID: 14942571
    [No Abstract]   [Full Text] [Related]  

  • 10. Reaction to diphenyl hydantoin sodium; report of a case simulating Rocky Mountain spotted fever and review of literature.
    STEINBERG SH
    Med Ann Dist Columbia; 1953 Nov; 22(11):600-3; passim. PubMed ID: 13098451
    [No Abstract]   [Full Text] [Related]  

  • 11. Diphenylhydantoin sensitivity. A case with exfoliative dermatitis and atypical lymphocytes in the peripheral blood.
    RANTAKALLIO P; FURUHJELM U
    Ann Paediatr Fenn; 1962; 8():146-51. PubMed ID: 14490300
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemopoietic complications of hydantoin therapy of epilepsy].
    MANNHEIMER E; PAKESCH F; REIMER EE; VETTER H
    Med Klin; 1952 Oct; 47(42):1397-1401. PubMed ID: 13001915
    [No Abstract]   [Full Text] [Related]  

  • 13. The metabolic conversion of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin) and of 5-ethyl-5-phenyl hydantoin (nirvanol) to 5 - ethyl -5- (p-hydroxyphenyl) hydantoin.
    BUTLER TC
    J Pharmacol Exp Ther; 1956 Jun; 117(2):160-5. PubMed ID: 13332557
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical results of the treatment of Sydenham's chorea with sodium diphenyl hydantoinate].
    DE la VEGA P
    Rev Clin Esp; 1947 Jan; 24(2):113-6. PubMed ID: 20243176
    [No Abstract]   [Full Text] [Related]  

  • 15. Ketogenic and other derivatives of hydantoin as anticonvulsants; further results.
    ORDWAY GL; PURO HE
    Stanford Med Bull; 1949 Nov; 7(4):157. PubMed ID: 15394886
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hydantoin exanthems with special reference to their fatal development].
    PIPER HG; VON ZEZSCHWITZ KA
    Dermatol Wochenschr; 1955; 132(45):1186-90. PubMed ID: 13285152
    [No Abstract]   [Full Text] [Related]  

  • 17. The metabolic fate of 5-ethyl-1-methyl-5-phenyl hydantoin (1-methylnirvanol) and that of 3,5-diethyl-5-phenyl hydantoin (3-ethylnirvanol).
    BUTLER TC; WADDELL WJ
    J Pharmacol Exp Ther; 1959 Nov; 127():171-4. PubMed ID: 13806515
    [No Abstract]   [Full Text] [Related]  

  • 18. [General review of the toxic side-effects caused by hydantoin derivatives used in epilepsy].
    FACCHETTI G
    Cervello G Nevrol; 1962 Mar; 38():147-60. PubMed ID: 13891254
    [No Abstract]   [Full Text] [Related]  

  • 19. The absorption spectra of organic compounds containing nitrogen; derivatives of hydantoin.
    STUCKEY RE
    J Chem Soc; 1947 Mar; 169():331-4. PubMed ID: 20240567
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of hydantoin (mesantoin) as an anticonvulsive drug.
    HARRIS TH; OTTO JL
    Tex State J Med; 1947 Sep; 43(5):328-30. PubMed ID: 20261615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.